High-throughput structural biology of metabolic enzymes and its impact on human diseases.
The Structural Genomics Consortium (SGC) is a public-private partnership that aims to determine the three-dimensional structures of human proteins of medical relevance and place them into the public domain without restriction. To date, the Oxford Metabolic Enzyme Group at SGC has deposited the struc...
Κύριοι συγγραφείς: | Yue, W, Oppermann, U |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2011
|
Παρόμοια τεκμήρια
-
High-throughput structural biology of metabolic enzymes and its impact on human diseases
ανά: Yue, W, κ.ά.
Έκδοση: (2011) -
High-throughput structural biology of metabolic enzymes and its impact on human diseases.
ανά: Yue, W, κ.ά.
Έκδοση: (2011) -
Structural genomics and high throughput structural biology /
ανά: Sundstrom, Michael, κ.ά.
Έκδοση: (2006) -
Structural genomics and drug discovery: Case studies on human metabolic enzymes
ανά: Oppermann, U, κ.ά.
Έκδοση: (2007) -
Molecular and structural aspects of xenobiotic carbonyl metabolizing enzymes. Role of reductases and dehydrogenases in xenobiotic phase I reactions.
ανά: Oppermann, U, κ.ά.
Έκδοση: (2000)